| 1 | 79940-41-3 | CYCLIC-DI-IMP | c-di-IMP | C20H22N8O14P2 | | |
| 2 | 79942-31-7 | 对甲基杯[6]芳烃 | P-METHYLCALIX[6]ARENE | C48H48O6 | | |
| 3 | 79942-37-3 | 3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID ETHYL ESTER | 3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID ETHYL ESTER | C14H20O2 | | |
| 4 | 79942-40-8 | 3-(4-ISOPROPYL-PHENYL)-PROPAN-1-OL | 3-(4-ISOPROPYL-PHENYL)-PROPAN-1-OL | C12H18O | | |
| 5 | 79942-64-6 | 3-乙酰基-2,2-二甲基环丙基甲酸乙酯 | Ethyl 2,2-dimethyl-3-(acetoxymethyl)cyclopropanecarboxylate | C11H18O4 | | |
| 6 | 79943-22-9 | (3aS,5R,6R,6aS)-5-((S)-2,2-二甲基-1,3-二氧戊环-4-基)-2,2-二甲基四氢呋喃[2,3-d][1,3]二氧戊环-6-醇 | 1,2:5,6-DI-O-ISOPROPYLIDENE-ALPHA-L-GLUCOFURANOSE | C12H20O6 | | |
| 7 | 79943-68-3 | HYDRA PEPTIDE | HYDRA PEPTIDE | C54H84N12O14 | 标准品 | |
| 8 | 79944-37-9 | 反式 5-氨基-6-羟基-2,2-二甲基-1,3-二氧杂环庚烷 | trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol | C7H15NO3 | 中间体;医药中间体 | |
| 9 | 79944-47-1 | 2,4,6-三碘-5-(N-甲基乙酰氨基)间苯二甲酰氯 | 1,3-Benzenedicarbonyl dichloride, 5-(acetylmethylamino)-2,4,6-triiodo- | C11H6Cl2I3NO3 | | |
| 10 | 79944-56-2 | Idazoxan Hydrochloride | Idazoxan Hydrochloride | C11H13ClN2O2 | 有机中间体;小分子抑制剂 | |
| 11 | 79944-58-4 | 亚达唑散 | Idazoxan | C11H12N2O2 | | |
| 12 | 79944-62-0 | 3-氯-5-硝基苯甲醇 | (3-CHLORO-5-NITROPHENYL)METHANOL | C7H6ClNO3 | | |
| 13 | 79944-63-1 | 3-氨基-5-氯苄醇 | (3-AMINO-5-CHLOROPHENYL)METHANOL | C7H8ClNO | | |
| 14 | 79944-64-2 | 3-氯-5-氟苄醇 | 3-Chloro-5-Fluorobenzyl Alcohol | C7H6ClFO | | |
| 15 | 79944-65-3 | 1-CHLORO-3-(CHLOROMETHYL)-5-FLUOROBENZENE | 1-CHLORO-3-(CHLOROMETHYL)-5-FLUOROBENZENE | C7H5Cl2F | | |
| 16 | 79945-42-9 | 4-(反-4-丙基环己基羰氧基)苯甲酸-4-氟苯酯 | 4-Fluorophenyl 4-(trans-4-propylcyclohexyl carbonyloxy)benzoate | | | |
| 17 | 79949-29-4 | | Palladium, dichlorobis(4-methyl-2-pyrimidinamine-N1)-, (SP-4-1)- (9CI) | C10H14Cl2N6Pd | | |
| 18 | 79949-30-7 | | Palladium, dichlorobis(2,4-diethoxy-5-methylpyrimidine-N1)-, (SP-4-1)- (9CI) | C18H28Cl2N4O4Pd | | |
| 19 | 79949-31-8 | | Palladium,bis(4-amino-2(1H)-pyrimidinone-N3)dibromo-, (SP-4-2)- (9CI) | C8H12Br2N6O2Pd | | |